Abstract
We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment for multiple sclerosis in the absence of any other systemic disease or underlying malignancy. More studies are needed to characterise the incidence of inflammatory vaginitis among women on long-term rituximab therapy.
Originalsprog | Engelsk |
---|---|
Artikelnummer | e250425 |
Tidsskrift | BMJ Case Reports |
Vol/bind | 15 |
Udgave nummer | 11 |
ISSN | 1757-790X |
DOI | |
Status | Udgivet - 2022 |
Bibliografisk note
Funding Information:Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for- profit sectors.
Publisher Copyright:
© BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.